<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Endoscopic biopsy surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is generally recommended </plain></SENT>
<SENT sid="1" pm="."><plain>However, optimal patient selection and frequency of follow-up are subject to ongoing discussion </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To investigate current surveillance practices for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in the Netherlands and to explore their concordance with the guidelines for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> surveillance as recommended by the International Society for Diseases of the Esophagus (ISDE) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: An anonymous questionnaire was mailed to 269 specialist physicians working in the field of gastroenterology </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The response rate was 88% (238/269) </plain></SENT>
<SENT sid="5" pm="."><plain>Most of the respondents (84%) performed regular endoscopic follow-up of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In 52%, endoscopic biopsy sampling corresponded to the ISDE guidelines (four-quadrant biopsies at 2 cm intervals) </plain></SENT>
<SENT sid="7" pm="."><plain>Agreement was 60% regarding the interval of surveillance for no <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (every 2 years), 52% regarding the interval for low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (every year) and 54% for management of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (oesophagectomy if diagnosis confirmed by a second pathologist or re-biopsy in the short term) </plain></SENT>
<SENT sid="8" pm="."><plain>When combining these three items, consistency with the ISDE guidelines decreased to 25% </plain></SENT>
<SENT sid="9" pm="."><plain>Criteria to select patients for surveillance included age, presence of symptoms, length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and type of <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The survey indicates widespread practice of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance for patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in the Netherlands </plain></SENT>
<SENT sid="11" pm="."><plain>However, there is limited uniformity in the frequency and intensity of endoscopic histological follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>This variability in clinical practice may result from conflicting data and recommendations in the literature </plain></SENT>
<SENT sid="13" pm="."><plain>Updated consensus is needed in this area </plain></SENT>
</text></document>